Outcomes Following Medical or Surgical Management of Endocarditis
A Review of Outcomes Following Medical or Surgical Management of Endocarditis
1 other identifier
observational
100
1 country
1
Brief Summary
Infective endocarditis is a rare disease, and while there have been several large reviews of the incidence of endocarditis in the pediatric patient population, relatively little has been published regarding the short and medium-term outcomes following medical and surgical therapy for this disease. The goal is to compare the outcome for children treated for endocarditis with either medical management or surgery by looking at the success of these two treatment strategies. Another goal is to attempt to identify risk factors for medical management that might identify patients who would be better served by early surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2005
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 12, 2005
CompletedFirst Posted
Study publicly available on registry
September 14, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2006
CompletedNovember 26, 2013
November 1, 2013
September 12, 2005
November 25, 2013
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- All patients discharged from Children's Healthcare of Atlanta at Egleston with a discharge diagnosis of endocarditis or those who underwent surgery with a preoperative diagnosis of endocarditis.
- Admitted to the hospital between January 1, 1984 - December 31, 2004, inclusive.
- Signed informed consent.
You may not qualify if:
- Patients who do not have documented endocarditis based upon microbiology and echocardiography criteria.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
Study Sites (1)
Children's Healthcare of Atlanta
Atlanta, Georgia, 30322, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul Kirshbom, MD
Emory University
Study Design
- Study Type
- observational
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 12, 2005
First Posted
September 14, 2005
Study Start
August 1, 2005
Study Completion
December 1, 2006
Last Updated
November 26, 2013
Record last verified: 2013-11